In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

BTG, Teva collaborate on generic drugs; rights later returned

Executive Summary

Savient's biologics manufacturing business Bio-Technology General Corp. (BTG) and Teva Pharmaceutical Industries will collaborate to develop and globally commercialize several generic recombinant therapeutic products.
Deal Industry
  • Pharmaceuticals
    • Generic Drugs
Deal Status
  • Terminated
Deal Type
  • Alliance
    • R+D and Marketing-Licensing

Related Companies

Advertisement
UsernamePublicRestriction

Register